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Bichat-Claude Bernard Hospital, Assistance Publique, Hôpitaux de Paris and 6) IAME, UMR 1137, INSERM, F-75018 Paris, FranceAbstractThe incidence of surgical site infection (SSI) after cardiac surgery depends on the deﬁnition used. A distinction is generally made between
mediastinitis, as deﬁned by the US Centers for Disease Control and Prevention (CDC), and superﬁcial SSI. Our objective was to
decipher these entities in terms of presentation and risk factors. We performed a 7-year single centre analysis of prospective surveillance
of patients with cardiac surgery via median sternotomy. SSI was deﬁned as the need for reoperation due to infection. Among 7170
patients, 292 (4.1%) developed SSI, including 145 CDC-deﬁned mediastinitis (CDC-positive SSI, 2.0%) and 147 superﬁcial SSI without
associated bloodstream infection (CDC-negative SSI, 2.1%). Median time to reoperation for CDC-negative SSI was 18 days (interquartile
range, 14–26) and 16 (interquartile range, 11–24) for CDC-positive SSI (p 0.02). Microorganisms associated with CDC-negative SSI were
mainly skin commensals (62/147, 41%) or originated in the digestive tract (62/147, 42%); only six were due to Staphylococcus aureus (4%),
while CDC-positive SSI were mostly due to S. aureus (52/145, 36%) and germs from the digestive tract (52/145, 36%). Risk factors for
SSI were older age, obesity, chronic obstructive bronchopneumonia, diabetes mellitus, critical preoperative state, postoperative
vasopressive support, transfusion or prolonged ventilation and coronary artery bypass grafting, especially if using both internal thoracic
arteries in female patients. The number of internal thoracic arteries used and factors affecting wound healing were primarily associated
with CDC-negative SSI, whereas comorbidities and perioperative complications were mainly associated with CDC-positive SSI. These 2
entities differed in time to revision surgery, bacteriology and risk factors, suggesting a differing pathophysiology.
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E-mail: jean-christophe.lucet@bch.aphp.frIntroductionSurgical site infection (SSI) is a severe complication after cardiac
surgery associated with signiﬁcant morbidity and mortality. Its
incidence varies between 1% and 3% (extremes, 0.5–10%)Microbiol Infect 2015; 21: 674.e11–674.e18
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2015.03.025depending on risk factors for SSI, compliance with preventive
measures, intensity of surveillance and the deﬁnition used for
mediastinitis [1–6].
The most commonly used deﬁnition is that of the US Cen-
ters for Disease Control and Prevention (CDC) (http://www.
cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf). It
includes at least one of the following criteria occurring within
90 days after the initial surgical procedure: organisms cultured
from mediastinal tissue or ﬂuid obtained during a surgical
operation or needle aspiration; evidence of mediastinitis
observed during surgery; fever, chest pain or sternal instabilityious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Lemaignen et al. Sternal wound infection after cardiac surgery 674.e12associated with either purulent discharge from the mediastinal
area; or organisms cultured from blood. This deﬁnition is not
anatomic in the strict sense because superﬁcial SSI with positive
blood culture enters into the spectrum of CDC-deﬁned
mediastinitis (CDC-positive SSI).
Many studies have examined and identiﬁed possible risk
factors associated with SSI [1,2,4,7–9]. The most frequently
reported risk factors are obesity, diabetes mellitus, coronary
artery bypass grafting (CABG) mainly using both internal
thoracic arteries (ITA) and peri- and postoperative complica-
tions. Few publications have examined differences between
superﬁcial and deep SSI [2,3,7] in terms of presentation and risk
factors.
We hypothesized that pathophysiology differs between
mediastinitis with CDC criteria (CDC-positive SSI) and SSI
requiring reoperation without CDC criteria (CDC-negative
SSI). The ﬁrst could occur from the inside to the outside, more
rapidly and with more virulent organisms due to perioperative
contamination, while the second could arise on the outside and
move inside, from the scar, with delayed onset and mainly due
to bacteria from the skin ﬂora. Consequently, risk factors and
characteristics of these entities may vary.
This study aimed to describe the incidence, bacteriologic
characteristics and time to onset of CDC-positive and -negative
SSI, and to assess variables associated with CDC-positive SSI
and -negative SSI.Materials and methodsPatients
We included patients operated on between January 2006 and
December 2012 in the cardiac surgery unit of a 950-bed uni-
versity hospital. All adults undergoing open-heart cardiac sur-
gery using full median sternotomy were eligible. Exclusion
criteria included isolated pericardial surgery (short procedure
without cardiopulmonary bypass), repair of heart wound
(opening outwards), cardiac surgery without full median ster-
notomy or missing information in patient ﬁles concerning initial
surgery.
Data collection
The study data were extracted from prospectively collected
databases. The ﬁrst included demographic, medical and surgical
data collected in the cardiac surgery department. Physicians
prospectively collected variables for each operated patient by
standardized observation. Patients were followed up during the
entire hospital stay, and news was regularly obtained remotely
from surgery. Patients were systematically referred to the
cardiac surgery unit for management in case of a complicatedClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infepostoperative course after hospital discharge. The second
database was collected by the infection control unit and
included information collected prospectively about each SSI,
including microbiologic data. Computerized ﬁles were checked
for data and merged for subsequent analysis.
Primary outcome
The sternal wound was assessed on a daily basis after surgery
for dehiscence of sternotomy, fever, local pain, redness,
secretion, purulent discharge or sternal instability. SSI was
deﬁned as need for reoperation for local or systemic infection
involving the sternotomy scar [10]. The classiﬁcation of reop-
eration for SSI or for a mechanical problem was validated with a
senior surgeon. For one surgical procedure, only the ﬁrst
reoperation for SSI suspicion was taken into account. Deep SSI
was deﬁned as the need for sternum bone reopening during
reoperation due to deep purulent discharge, sternal bone
destruction or dehiscence. Deep sternal osteomyelitis fell in
this category; otherwise, SSI was classiﬁed as superﬁcial. CDC-
positive SSI was deﬁned as either deep SSI or superﬁcial SSI with
at least one positive blood culture with the same organism as in
the surgical sample, according to CDC criteria (http://www.cdc.
gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf). CDC-
negative SSI was deﬁned as a superﬁcial SSI without positive
blood culture.
Variables of interest
Variables were selected in the database according to the liter-
ature and separated into 3 groups. Preoperative characteristics
included age with a cutoff at 70 years [11], sex, body mass index
(BMI) with a cutoff at 30 kg/m2 deﬁning obesity, patient medical
history, including diabetes mellitus (absent, non-insulin-
dependent or insulin requiring), arterial hypertension, hyper-
cholesterolemia, smoking history, chronic obstructive pulmo-
nary disease (COPD), dialysis, history of cardiac surgery,
transluminal angioplasty or thoracic radiotherapy and clin-
icobiological data, serum creatinine level [12] and left ventric-
ular ejection fraction, with a cutoff at 50% deﬁning left
ventricular dysfunction. Preoperative mortality risk status was
assessed using the composite standard European System for
Cardiac Operative Risk Evaluation (EuroSCORE) [13]. Preop-
erative critical state, used to calculate the EuroSCORE, was
isolated as a preoperative variable. It was deﬁned as one or
more of the following: acute renal failure, need for mechanical
ventilation or catecholamines before entering the operating
room, cardiogenic shock before surgery, ventricular tachy-
cardia, ﬁbrillation or aborted sudden death, preoperative car-
diac massage or need for intra-aortic balloon counterpulsation.
Surgical variables combined the following: type of surgery,
such as valvular repair, CABG plus number of ITA used, bothctious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
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deﬁned as an unplanned procedure required within 24 hours;
duration of aortic clamping; and duration of cardiopulmonary
bypass.
Postoperative variables included transfusion, postoperative
use of catecholamines, duration of ventilation or inotropic drug
support more than 48 hours after surgery and length of stay in
an intensive care unit.
Time to revision surgery was recorded, and date of surgery
was considered to be the date of infection, as the exact date of
onset of signs was not recorded.
Bacteriologic data included results of microbiologic samples
during the ﬁrst reoperation and results of blood culture. Or-
ganisms were classiﬁed into six groups: undocumented, Staph-
ylococcus aureus, bacteria from skin ﬂora including coagulase-
negative staphylococci, germs of digestive origin (Enter-
obacteriaceae, enterococci, anaerobes from gut ﬂora, yeast and
Pseudomonas aeruginosa), other organisms (streptococci) and
polymicrobes (several different classes of bacteria considered
to be responsible for SSI in intraoperative samples). To assign
SSI to germs of the skin ﬂora, at least two samples had to be
positive for the same bacteria.
Statistical analysis
All statistical analyses were performed using R software,
version 3.1.
On the basis of monitoring data, the number of individuals
during the 7 years was sufﬁcient to detect a signiﬁcant odds
ratio of 1.3 for an exposure rate of 25% in the population and
an odds ratio of 2 for an exposure rate of 3%, with a power of
80%.
Remaining missing data in included ﬁles were imputed by a
chained equation using the MICE package in R [14].
Differences in absolute frequencies between patients with
and without SSI and between each group were analysed by a
two-tailed Fisher’s exact test; differences in median values were
analysed by a nonparametric Mann-Whitney test.
Variables suggested by univariate analysis (p < 0.1) and
judged to be clinically important or signiﬁcant interaction fac-
tors were entered into a complete logistic regression analysis
model. The ﬁnal risk model was selected using Akaike criteria in
a backward step-by-step comparison and was ﬁrst evaluated for
‘all SSI’ and then separately for ‘CDC-negative SSI’ and ‘CDC-
positive SSI.’p values of <0.05 were considered to indicate
statistical signiﬁcance on two-tailed testing. Goodness of ﬁt was
evaluated by the Le Cessie–van Houwelingen test [15]. Model
discrimination was assessed with the area under the receiver
operating characteristics curve, derived from the same set of
patients and computed by nonparametric methods for each of
the three models.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectResultsClinical data and incidence
Among 7275 patients with median sternotomy, 7170 met the
inclusion criteria (Fig. 1). Their clinical characteristics are
summarized in Table 1. Distribution of missing data was stable
over time and between subgroups, and did not exceed 8% per
variable.
Overall, 292 patients developed SSI (4.1%) requiring reoper-
ation. Among them, 145 (2.0%) met CDC criteria for media-
stinitis (CDC-positive SSI) and 147 (2.1%) were CDC negative.
Among CDC-positive SSI, 98 were deep SSI and 47 were su-
perﬁcial SSI, with positive blood culture. Depending on the type
of surgery and the number of ITA used, the global SSI incidence
was variable, at 1.4% (n = 46/3365) after valvular surgery, 7.3%
(n = 194/2669) after CABG, 5.8% (n = 44/758) after a combined
procedure and 2.1% (n = 8/378) after other types of surgery.
Time to reoperation and microbiologic documentation
Median time to reoperation was 17 days (interquartile range
(IQR), 12–25) for all SSI, 18 (IQR, 13.5–26) for CDC-negative
SSI and 16 (IQR, 11–24) for CDC-positive SSI (p 0.02). Among
CDC-positive SSI, patients with deep SSI were reoperated
earlier than patients with superﬁcial SSI with positive blood
culture, with a median time to reoperation of 14 (IQR, 10–21)
and 22 (IQR, 13–29) days, respectively.
Microorganisms associated with all SSI were of gastrointes-
tinal origin in 114 (39%) cases and skin commensal in 87 (30%)
cases. Both types of microorganisms were more frequent in
CDC-negative SSI—62 (42%) and 60 (41%), respectively—and
S. aureus was uncommon. S. aureus was the most frequent
microorganism in CDC-positive SSI (52, 36%), together with
pathogens from gastrointestinal ﬂora (n = 52, 36%). S. aureus
was associated with nearly half (n = 22, 47%) of the superﬁcial
SSI infections having positive blood cultures. Finally, 28 (10%)
SSI were polymicrobial, equally distributed in each group
(Table 2).
Variables associated with SSI
Table 3 shows variables associated with SSI in univariate anal-
ysis. An interaction existed between sex and diabetes mellitus
and between sex and the number of ITA used.
Variables associated with SSI in the ﬁnal global multivariate
model were older age, obesity, COPD, diabetes mellitus, pre-
operative higher serum creatinine level, critical preoperative
status, CABG using one ITA (or, even worse, two ITA), need
for perioperative blood transfusion or vasopressive support,
prolonged mechanical ventilation and interaction term between
female sex and number of ITA (Table 4).ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
FIG. 1. Flowchart. TAVI, transaortic
valve implantation; PM, pacemaker;
ECMO, extracorporeal membrane
oxygenation; SSI, sternal site infection;
CDC− SSI, superﬁcial SSI without US
Centers for Disease Control and Pre-
vention (CDC)–deﬁned criteria of
mediastinitis; CDC+ SSI, SSI with CDC-
deﬁned criteria of mediastinitis; SSSI+,
superﬁcial SSI with positive blood cul-
ture; DSSI, deep anatomic SSI.
CMI Lemaignen et al. Sternal wound infection after cardiac surgery 674.e14Variables associated with CDC-negative SSI were obesity,
diabetes mellitus, critical preoperative status, higher preoper-
ative serum creatinine level, CABG with both ITA and the
interaction term between sex and ITA, indicating a higher risk
of CABG in women.
Variables associated with CDC-positive SSI were older age,
obesity, COPD, insulin-requiring diabetes mellitus, critical
preoperative status, CABG using one or two ITA and compli-
cated postoperative course and either vasopressive support,
prolonged mechanical ventilation or need for perioperative
transfusion.
Goodness of ﬁt was not signiﬁcant for the three models (p
values, respectively, of 0.63, 0.88 and 0.32), and the areas under
the receiver operating characteristics curve of the models were
0.81, 0.86 and 0.78.
In previous analyses, early surgical revision for noninfectious
reasons could not be assessed because of uncertain data
collection for this variable in noninfected persons. We there-
fore conducted an analysis limited to the 292 patients with SSI
so as to assess differences between CDC-negative SSI and
CDC-positive SSI, because information on early surgicalClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inferevision was available for all infected patients. A signiﬁcant risk
factor associated with CDC-positive SSI was early surgical
revision (adjusted odds ratio 2.9; 95% conﬁdence interval
1.2–7.4), whereas diabetes mellitus appeared protective
(adjusted odds ratio 0.43; 95% conﬁdence interval 0.22–0.82)
(Appendix).DiscussionIn our study, the incidence, presentation, associated microor-
ganisms and risk factors differed according to the deﬁnition
used for SSI.
Risk factors for overall SSI were consistent with those in the
literature [2,5,8,9,16]. As in most publications, obesity, diabetes
mellitus and other preoperative comorbidities, critical preop-
erative status, CABG (especially with one or both ITA) and a
complicated postoperative course were associated with SSI.
On the basis of the assumption that pathophysiology may
differ according to the type of SSI, we differentiated CDC-
positive SSI, so-called mediastinitis and CDC-negativectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
TABLE 2. Time to SSI and microbiologic documentation in 292 SS
Time to reoperation, median (IQR)
All SSI
(n [ 292)
CDC-negative
SSI (n [ 147)
Microbiologic documentation, n (%) 17 (12–25) 18 (14–26)
Commensal skin ﬂora 87 (29.8) 60 (40.8)
CoNS 82 (28.1) 54 (36.7)
Other 7 (2.4) 7 (4.8)
Digestive origin 114 (39.0) 62 (42.2)
Enterobacteriaceae 70 (24.0) 35 (23.8)
Enterococcus spp. 16 (5.5) 10 (6.8)
Both 18 (6.2) 11 (7.5)
Pseudomonas aeruginosa 13 (4.5) 6 (4.1)
Staphylococcus aureus 58 (19.9) 6 (4.1)
MSSA 53 (18.2) 6 (4.1)
MRSA 5 (1.7) 0
Other 2 (0.7) 1 (0.7)
Polymicrobial 28 (9.6) 17 (11.6)
SA 6 (2.1) 3 (2.0)
CoNS 23 (7.9) 14 (9.5)
Enterobacteriaceae 15 (5.1) 6 (4.1)
Enterococcus spp. 5 (1.7) 4 (2.7)
Not documented 3 (1.0) 1 (0.7)
Total percentages may exceed 100% within a class of pathogens when several germs of the
SSI, sternal site infection; CDC, US Centers for Disease Control and Prevention; CDC-negativ
deﬁned mediastinitis; SSSI, superﬁcial SSI with positive blood culture; DSSI, deep anatomical SS
sensitive Staphylococcus aureus; MRSA, MSSA, methicillin-resistant S. aureus.
TABLE 1. Clinical characteristics of 7170 patients undergoing
cardiac surgery, Bichat Hospital, 2006–2012
Characteristic Value
Missing
values
Age, median (IQR) 65.6 (55.4–74.9) 0
Sex, M/F 4920/2250 0
EuroSCORE, median (IQR) 6 (4–8) 0
Immunodeﬁciency 269 (3.75%) 0
Median BMI (kg/m2), median (IQR) 26 (23.4–29.1) 0
Obesity (BMI >30 kg/m2) 1416 (19.7%) 32 (0.45%)
Non-insulin-dependent diabetes mellitus 1293 (18%) 4 (0.06%)
Insulin-dependent diabetes mellitus 579 (8.1%)
Arterial hypertension 4123 (57.5%) 0
Hypercholesterolemia 3675 (51.3%) 10 (0.14%)
Smoking history 3737 (52.1%) 0
Sternotomy history 743 (10.4%) 0
PCI history 912 (12.7%) 7 (0.1%)
History of thoracic radiotherapy 142 (1.98%) 15 (0.2%)
COPD 824 (11.5%) 29 (0.4%)
Dialysis 101 (1.41%) 10 (0.14%)
Critical preoperative status 596 (8.3%) 0
LVEF <50% 1875 (28.9%) 337 (4.7%)
Serum creatinine >130 μmol/L 760 (6.2%) 384 (5.4%)
Surgical emergency 818 (11.4%) 0
Isolated valve surgery 3365 (46.9%) 0
Isolated coronary surgery (CABG) 2669 (37.2%) 0
Combined valve and coronary surgery 758 (10.6%) 0
Other surgery 378 (5.3%) 0
Duration of aortic clamping (minutes), median
(IQR)
46 (36–64) 137 (1.9%)
Duration of cardiopulmonary bypass
(minutes), median (IQR)
205 (187–221) 76 (1.1%)
Early surgical revision (<7 days) 750 (10.3%) 87 (1.2%)
Perioperative transfusion 3095 (43.2%) 77 (1.1%)
Vasopressive support 3376 (47.1%) 82 (1.1%)
Duration of catecholamines (hours), median
(IQR)
28 (16–48) 576 (8%)
Duration of ventilation (hours), median (IQR) 7 (5–10) 140 (1.9%)
Duration of ICU stay (days), median (IQR) 3 (2–5) 10 (0.1%)
Duration of hospital stay (days), median (IQR) 10 (7–14) 32 (0.4%)
All-cause mortality at 90 days 395 (5.5%) 0
All data are presented as n (%) unless indicated otherwise.
IQR, interquartile range; EuroSCORE, European System for Cardiac Operative Risk
Evaluation; BMI, body mass index; PCI, percutaneous coronary intervention;
COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection
fraction; CABG, coronary artery bypass grafting; ICU, intensive care unit.
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Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectinfection requiring reoperation. Patients with mediastinal
involvement had SSI occurring after a shorter median time,
often associated with S. aureus. In contrast, CDC-negative SSI
occurred signiﬁcantly later, and microorganisms from the
commensal skin ﬂora were most frequently involved.
These variations suggest a differing pathophysiology for SSI.
Anatomic mediastinitis is an early infection due to more viru-
lent microorganisms, with contamination of the wound likely
occurring during the surgical procedure or the ﬁrst post-
operative days. The route of contamination may be direct
inoculation of the wound during the surgical procedure, or
hematogenous contamination from a remote source such as a
catheter [17] or digestive translocation in patients with post-
operative unstable hemodynamic status. Risk factors for CDC-
positive SSI support this hypothesis. Indeed, a postoperative
complicated course was a risk factor for SSI in this population,
but not in the population with CDC-negative SSI only.
In patients with reoperation for CDC-negative SSI infection,
later time to infection and involvement of commensal skin ﬂora
support the hypothesis of infection occurring in patients with
delayed wound healing. To further support this hypothesis,
CABG of both ITA, especially in women, was strongly associ-
ated with CDC-negative SSI and to a lesser extent with CDC-
positive SSI and direct comparison between CDC-positive and
CDC-negative subgroups showed an association between dia-
betes mellitus and CDC-SSI. Both diabetes mellitus and CABG
of both ITA are well-established risk factors for delayed healing
[18]. In addition, collecting ITA deprives the sternum of
vascular ﬂow to the anterior chest wall, thus increasing the risk
of delayed wound healing.I, Bichat Hospital, 2006–2012
CDC-positive
SSI (n [ 145)
CDC-positive SSI:
SSSI (n [ 47)
CDC-positive SSI
DSSI (n [ 98)
16 (11–24) 22 (13–29) 14 (10–21)
26 (17.9) 10 (21.3) 17 (17.3)
26 (17.9) 10 (21.3) 17 (17.3)
1 (0.7) 0 1 (1.0)
54 (37.2) 10 (21.3) 42 (42.9)
36 (24.8) 7 (14.9) 27 (27.6)
6 (4.1) 0 6 (6.1)
7 (4.8) 3 (6.4) 4 (4.1)
5 (3.4) 1 (2.1) 4 (4.1)
52 (35.9) 22 (46.8) 30 (30.6)
47 (32.4) 19 (40.4) 28 (28.6)
5 (3.4) 3 (6.4) 2 (2.0)
1 (0.7) 0 1 (1.0)
11 (7.6) 5 (10.6) 6 (6.1)
2 (1.4) 1 (2.1) 2 (2.0)
5 (3.4) 5 (10.6) 3 (3.1)
6 (4.1) 4 (8.5) 5 (5.1)
1 (0.7) 0 1 (1.0)
2 (1.4) 0 1 (1.0)
same origin are found.
e SSI, superﬁcial SSI without positive blood cultures; CDC-positive SSI, SSI with CDC-
I; IQR, interquartile range; CoNS, coagulase-negative staphylococci; MSSA, methicillin-
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
TABLE 4. Variables associated with SSI, multivariate analysis, Bichat Hospital, 2006–2012
SSI (n [ 292)
aOR (95%CI) P
CDC-negative SSI
(n [ 147)
aOR (95%CI) P
CDC-positive SSI
(n [ 145)
aOR (95%CI) P
Age > 70 years 1.3 (1.0–1.7) 0.03 1.2 (0.8–1.7) 0.10 1.4 (1.0–2.1) 0.03
Obesity (BMI > 30 kg/m2) 2.4 (1.9–3.2) <0.01 2.5 (1.7–3.6) <0.01 2.3 (1.6–3.4) <0.01
COPD 1.4 (1.0–2.0) 0.04 1.3 (0.8–2.2) 0.08 1.6 (1.0–2.5) 0.04
NIDDM 1.7 (1.2–2.3) <0.01 2.8 (1.9–4.3) <0.01 1.0 (0.7–1.6) >0.1
IDDM 2.7 (1.9–3.8) <0.01 4.2 (2.6–6.6) <0.01 1.8 (1.1–2.9) 0.01
Critical pre-operative status 2.0 (1.4–2.9) <0.01 2.2 (1.3–3.8) <0.01 2.0 (1.2–3.1) <0.01
Serum creatinine > 130 μmol/L 1.3 (0.9–1.9) 0.06 1.6 (1.0–2.6) 0.046 1.1 (0.7–2.0) >0.1
1 ITA 2.1 (1.1–4.1) 0.02 0.9 (0.2–4.2) >0.1 2.8 (1.3–5.8) <0.01
2 ITAs 3.9 (2.6–5.8) <0.01 5.2 (2.6–10.4) <0.01 3.3 (2.0–5.6) <0.01
Vasopressive support 1.4 (1.1–1.9) <0.01 1.1 (0.8–1.6) >0.1 1.9 (1.2–2.8) <0.01
Ventilation duration > 48 h 2.0 (1.4–2.9) <0.01 1.4 (0.8–2.5) >0.1 2.4 (1.5–3.7) <0.01
Perioperative transfusion 1.3 (1.0–1.8) 0.05 1.1 (0.7–1.6) >0.1 1.5 (1.0–2.3) 0.04
Female gender 0.9 (0.5–1.5) >0.1 0.8 (0.3–2.2) >0.1 0.9 (0.5–1.8) >0.1
Interaction female/1 ITA 2.1 (0.8–5.5) 0.10 9.6 (1.5–61.2) 0.02 1.0 (0.3–3.3) >0.1
Interaction female/2 ITA 3.5 (1.8–6.3) <0.01 5.4 (1.9–15.5) <0.01 1.7 (0.7–4.0) >0.1
Abbreviations: SSI, surgical site infection; CDC, Centers for Disease Control; CDC-negative SSI, superﬁcial SSI without CDC-deﬁned criteria for mediastinitis; CDC-positive SSI,
SSI with CDC-deﬁned mediastinitis; BMI, body mass index; COPD, chronic obstructive pulmonary disease; NIDDM, non-insulin-dependent diabetes mellitus; IDDM,
insulin-dependent diabetes mellitus; ITA, internal thoracic artery; aOR, adjusted odds ratio; 95% CI, 95% conﬁdence internal.
TABLE 3. Univariate analysis of variables associated with SSI, Bichat Hospital, 2006–2012
Variable
No SSI (n [ 6878) All SSI (n[ 292)
p
CDC-negative SSI
(n [ 147)
p
CDC-positive SSI
(n [ 145)
pValue Value Value Value
Preoperative risk factors
Age >70 years 2572 (37.4) 137 (46.9) 0.006 63 (42.9) 74 (51) <0.001
Female sex 2141 (31.3) 109 (37.3) 0.028 66 (44.9) <0.001 43 (29.7)
EuroSCORE, median (IQR) 6 (4–8) 7 (5–10) <0.001 7 (5–9) <0.001 8 (6–10) <0.001
Immunodeﬁciency 249 (3.6) 20 (6.8) 0.01 9 (6.1) 11 (7.6) 0.04
Obesity (BMI >30 kg/m2) 1296 (18.8) 120 (41.1) <0.001 67 (45.6) <0.001 53 (36.6) <0.001
NIDDM 1209 (17.6) 84 (28.8) <0.001 53 (36.1) <0.001 31 (21.4)
IRDM 503 (7.3) 76 (26) <0.001 48 (32.7) <0.001 28 (19.3) <0.001
Arterial hypertension 3903 (56.7) 219 (75) <0.001 116 (78.9) <0.001 103 (71) 0.001
Hypercholesterolemia 3487 (50.7) 188 (64.4) <0.001 107 (72.8) <0.001 81 (55.9)
Smoking history 3580 (52.1) 157 (54) 78 (53.1) 76 (54.5)
Sternotomy history 731 (10.6) 12 (4.1) <0.001 2 (1.4) <0.001 10 (6.9)
COPD 778 (11.3) 46 (15.8) 0.017 19 (12.9) 27 (18.6) 0.004
Dialysis 89 (1.3) 12 (4.1) <0.001 5 (3.4) 0.03 7 (4.8) 0.005
Critical preoperative status 540 (7.9) 56 (19.2) <0.001 24 (16.3) 0.002 32 (22.1) <0.001
LVEF <50% 1756 (25.5) 119 (40.8) <0.001 62 (42.2) <0.001 57 (39.3) <0.001
Serum creatinine >130 μmol/L 706 (10.3) 54 (18.5) <0.001 29 (19.7) <0.001 25 (17.2) 0.007
Surgical risk factors
Surgical emergency 770 (11.2) 48 (16.4) 0.008 21 (14.3) 27 (18.6) 0.007
Surgical procedure
Valve surgery 3319 (48.3) 46 (15.8) 15 (10.2) 31 (21.4)
Other surgery 370 (5.4) 8 (2.7) 2 (1.4) 6 (4.1)
Combined surgery 714 (10.4) 44 (15.1) <0.001 17 (11.6) <0.001 27 (18.6) <0.001
Coronary surgery 2475 (36) 194 (66.4) <0.001 113 (76.9) <0.001 81 (55.9) <0.001
No. of ITA used
|
With no ITA 3774 (54.9) 56 (19.2) 17 (11.6) 39 (26.9)
With 1 ITA 557 (8.1) 28 (9.6) <0.001 10 (6.8) <0.001 18 (12.4) <0.001
With 2 ITA 2547 (3) 208 (71.2) <0.001 120 (81.6) <0.001 88 (60.7) <0.001
Duration of AoC, median (IQR) 46 (36–64) 41 (34–54) <0.001 41 (32–49) <0.001 44 (36–57.8)
Duration of cardiopulmonary bypass,
median (IQR)
205 (187–222) 203.5 (191–218) 203 (190–212) 205 (191–220)
Postoperative risk factors
Perioperative transfusion 2926 (42.5) 169 (57.9) <0.001 81 (55.1) 0.001 88 (60.7) <0.001
Vasopressive support 3193 (46.4) 183 (62.7) <0.001 80 (54.4) 0.052 103 (71) <0.001
Catecholamine duration >2 days 993 (14.4) 79 (27.1) <0.001 33 (22.4) 0.047 47 (32.4) <0.001
Ventilation duration >2 days 601 (8.7) 64 (21.9) <0.001 23 (15.6) 0.008 41 (28.3) <0.001
Duration of ICU stay
48 hours 3062 (44.5) 95 (32.5) 51 (34.7) 44 (30.3)
7 days 950 (13.8) 68 (23.3) <0.001 25 (17) 0.06 43 (29.7) <0.001
SSI, sternal site infection; CDC, US Centers for Disease Control and Prevention; CDC-negative SSI, superﬁcial SSI requiring reoperation without CDC-deﬁned criteria for
mediastinitis; CDC-positive SSI, SSI with CDC-deﬁned mediastinitis; CDC-positive SSSI, superﬁcial SSI with positive blood culture; CDC-positive DSSI, deep anatomical SSI; IQR,
interquartile range; EuroSCORE, European System for Cardiac Operative Risk Evaluation; BMI, body mass index; NIDDM, non-insulin-dependent diabetes mellitus; IDDM, insulin-
dependent diabetes mellitus; PCI, percutaneous coronary intervention; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; ITA, internal thoracic
artery; AoC, aortic clamping; ICU, intensive care unit.
CMI Lemaignen et al. Sternal wound infection after cardiac surgery 674.e16
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
Variable
Univariate analysis Multivariate analysis
OR (95% CI) p aOR (95% CI) p
Preoperative risk factors
Age >70 years 1.4 (0.88–2.2) 0.16 1.3 (0.76–2.3)
Female sex 0.52 (0.32–0.84) <0.01 0.99 (0.28–3.5)
EuroSCORE (per unit) 1.0 (0.98–1.1)
Immunodeﬁciency 1.3 (0.51–3.1)
Obesity (BMI >30
kg/m2)
0.73 (0.46–1.2) 0.19 0.99 (0.56–1.7)
NIDDM 0.31 (0.18–0.55) <0.01 0.43 (0.22–0.82) 0.01
IDDM 0.31 (0.17–0.56) <0.01 0.42 (0.21–0.86) 0.02
Arterial hypertension 0.66 (0.38–1.12)
Hypercholesterolemia 0.51 (0.32–0.84) 0.008
Smoking history 1.1 (0.67–1.7)
COPD 1.5 (0.81–2.9) 0.18 1.4 (0.68–2.8)
674.e17 Clinical Microbiology and Infection, Volume 21 Number 7, July 2015 CMIThe interaction between CABG and one or both ITA, along
with female sex, were strongly associated with CDC-negative
SSI. Indeed, tension of the breast upon the skin wound may
be an additional risk factor for delayed wound healing and
wound leakage, leading to SSI. Identiﬁcation of these associated
risk factors should lend impetus to development of appropriate
preventive measures. In our unit, we recommend that women
wear a chest corset during the ﬁrst postoperative days in order
to facilitate sternal healing and avert wound leakage. If our
hypothesis is conﬁrmed by other studies, this preventive
measure could be extended to a longer period after cardiac
surgery. Other preventive measures, such as a sternal ﬁxation
plate [19], might be proposed, although the presence of foreign
body could increase the SSI risk. Similarly, cautious skin care
monitoring and careful postoperative dressing should be
continued until complete wound healing in patients at high risk.
In any case, our data clearly support the need for exploring
postoperative preventive measures, notably by facilitating
wound healing and limiting wound contamination, as recently
suggested [17].
Conversely, most risk factors associated with CDC-positive
SSI were nonmodiﬁable. Collecting both ITA could be chal-
lenged in case of associated risk factors, but this surgical
technique has been shown to markedly improve grafting
patency [1].
Direct comparison of CDC-positive and CDC-negative SSI
further supports the hypothesis of differing pathophysiologies.
Early reoperation was associated with CDC-positive SSI, in line
with a complicated postoperative course in the population of
operated patients, whereas diabetes mellitus was speciﬁcally
associated with CDC-negative SSI.
In patients with CDC-positive SSI, two different patterns
were observed. In CDC-positive SSI deﬁned by positive blood
culture, but without the need for sternum reopening, infec-
tion occurred late, with time to reoperation similar to that of
CDC-negative SSI. The fact that half of these infections were
due to S. aureus suggests that they have the same patho-
physiology as CDC-negative SSI, but with a more virulent
microorganism, explaining the positive blood cultures. Thus,
the distinction between deep and superﬁcial SSI may be more
informative in terms of pathophysiology than the current
CDC deﬁnition of mediastinitis, whereas CDC-deﬁned
mediastinitis may be more relevant in terms of morbidity
and outcome.
The main strength of this study was the large population
included over a long time period, the completeness of the data
and the reproducibility and robustness of surveillance, per-
formed by the same infection control team.
Our study has several limitations. First, the single-centre na-
ture of this study limited generalization of our results. SurgicalClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectprocedures may vary from one centre to another, especially in
terms of the propensity to reoperate a patient if SSI is suspected.
In addition, patient characteristics may vary depending on local
recruitment. Finally, most CABG at our centre are performed
via both ITA, given the long-term patency of this revasculariza-
tion technique. However, this probably has an impact on the risk
proﬁle and SSI incidence, especially for late SSI. Using the time to
reoperation to approximate the time to infection onset could
have led to a bias in the difference between CDC-negative SSI
and CDC-positive SSI. Some mild superﬁcial infection could have
been treated medically before intervention, thus increasing the
delay; however, this approximation seemed acceptable because
in our centre, the surgical team used to reoperate systematically
soon after the ﬁrst signs of SSI. Finally, SSIs not requiring surgery
were not followed up, which could have led to misclassiﬁcation
bias. This mainly pertains to superﬁcial infections with no general
impact, whose differentiation, by dehiscence related to poor
wound healing, may be difﬁcult.
In conclusion, SSI after cardiac surgery is not a rare
complication in our experience, and is burdened by signiﬁcant
morbidity and mortality. We suggest that its pathophysiology
differs between mediastinitis with mediastinal involvement and
severe superﬁcial SSI requiring reoperation. Our data strongly
suggest that preventive measures should be extended to the
postoperative period.Transparency declarationAll authors report no conﬂicts of interest relevant to this
article.APPENDIX. Variables associated with 145
cases of CDC-deﬁned mediastinitis in 292
patients with SSI, Bichat Hospital, 2006–2012ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 674.e11–674.e18
Continued
Variable
Univariate analysis Multivariate analysis
OR (95% CI) p aOR (95% CI) p
Dialysis 1.4 (0.46–4.1) 0.57 2.2 (0.5–9.6)
Critical preoperative
status
1.4 (0.81–2.6) 0.21 1.2 (0.59–2.4)
LVEF <50% 1.1 (0.69–1.7)
Creatinine >130 μmol/
L
0.91 (0.53–1.6) 0.7 0.77 (0.37–1.6)
Surgical risk factors
Surgical emergency 1.4 (0.74–2.6)
No. of ITA used for CABG
1 ITA 0.78 (0.3–2.0) 0.6 3.3 (0.56–19.1)
2 ITA 0.32 (0.17–0.60) <0.01 0.66 (0.27–1.6)
Aortic clamping (per
minute)
1.01 (1–1.03) 0.02
Cardiopulmonary
bypass (per minute)
0.99 (0.99–1)
Interaction female/1
ITA
0.12 (0.01–1.2)
Interaction female/2
ITA
0.34 (0.08–1.4)
Postoperative risk factors
Early surgical revision
(<7 days)
3.1 (1.3–7.2) 2.9 (1.2–7.4) 0.02
Perioperative
transfusion
1.3 (0.84–2.1) <0.01 1.4 (0.78–2.5)
Postoperative amines 2.1 (1.3–3.4) <0.01 1.7 (0.96–3.1)
Amine duration >48
hours
1.7 (0.98–2.8)
Ventilation duration
>48 hours
2.1 (1.2–3.8) 0.01 1.3 (0.65–2.7)
p values are indicated in the univariate analysis when p < 0.05 and for variables used
in the multivariate analysis; p values are indicated in the multivariate analysis when
p < 0.05.
CDC, US Centers for Disease Control and Prevention; SSI, sternal site infection;
OR, odds ratio; CI, conﬁdence interval; aOR, adjusted odds ratio; EuroSCORE,
European System for Cardiac Operative Risk Evaluation; BMI, body mass index;
NIDDM, non-insulin-dependent diabetes mellitus; IDDM, insulin-dependent
diabetes mellitus; HTN, arterial hypertension; SA, Staphylococcus aureus; COPD,
chronic obstructive pulmonary disease; LVEF, left ventricle ejection fraction; ITA,
internal thoracic artery; CABG, coronary artery bypass grafting.
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